Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals

NCT02980016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4027

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
HIV

Interventions

DRUG: rifapentine + isoniazid
DRUG: Isoniazid

Sponsor

The Aurum Institute NPC

Collaborators

[object Object]
[object Object]
[object Object]